Traws Pharma, Inc. · NASDAQ:TRAW

Ayrton Capital LLC reported a 9.90% stake in Traws Pharma, Inc. (Schedule 13G)

Event Dec 31, 2024 · Filed Feb 13, 2025

Ayrton Capital LLC reported a 9.90% stake in Traws Pharma, Inc., 403,650 shares, as a passive investor on Dec 31, 2024. Filed Feb 13, 2025 (Schedule 13G).

Stake
9.90%
Shares
403,650
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Ayrton Capital LLC9.90%403,650
Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B9.90%403,650
Waqas Khatri9.90%403,650

Source

View original at SEC

Related